Money, Banking & Me
SEE OTHER BRANDS

Get your daily news on finance and banking

Money, Banking & Me: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Money, Banking & Me.

Press releases published on May 6, 2025

Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

CAMBRIDGE, Mass., May 06, 2025 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today announced that on May 1, 2025, it awarded an …

CRISPR Therapeutics Provides First Quarter 2025 Financial Results and Announces Positive Top-Line Data from Phase 1 Clinical Trial of CTX310™ Targeting ANGPTL3

CRISPR Therapeutics Provides First Quarter 2025 Financial Results and Announces Positive Top-Line Data from Phase 1 Clinical Trial of CTX310™ Targeting ANGPTL3

-Initial CTX310™ Phase 1 clinical data demonstrates dose-dependent decreases in triglycerides (TG) and low-density lipoprotein (LDL), with peak reduction of up to 82% in TG and up to 81% in LDL, with a well-tolerated safety profile; presentation …

Lyra Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update

Lyra Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update

WATERTOWN, Mass., May 06, 2025 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (Nasdaq: LYRA) (“Lyra” or the “Company”), a clinical-stage biotechnology company developing long-acting, anti-inflammatory sinonasal implants for the treatment of chronic …

Denali Therapeutics Reports First Quarter 2025 Financial Results and Business Highlights Including Completion of BLA Rolling Submission for Tividenofusp Alfa for Hunter Syndrome

Denali Therapeutics Reports First Quarter 2025 Financial Results and Business Highlights Including Completion of BLA Rolling Submission for Tividenofusp Alfa for Hunter Syndrome

SOUTH SAN FRANCISCO, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (Nasdaq: DNLI) today reported financial results for the first quarter ended March 31, 2025, and provided business highlights. “The completion of our BLA submission for …

Ultragenyx Reports First Quarter 2025 Financial Results and Corporate Update

Ultragenyx Reports First Quarter 2025 Financial Results and Corporate Update

First quarter total revenue of $139 million, Crysvita® revenue of $103 million and Dojolvi® revenue of $17 million Reaffirm 2025 Financial Guidance: Total revenue between $640 million to $670 million, Crysvita revenue of $460 million to $480 million, and …

Day One Reports First Quarter 2025 Financial Results and Corporate Progress

Day One Reports First Quarter 2025 Financial Results and Corporate Progress

OJEMDA™ (tovorafenib) prescriptions grew 16% in Q1 2025 compared to Q4 2024 Achieved Q1 2025 OJEMDA™ (tovorafenib) net product revenue of $30.5 million Ended the first quarter with $473.0 million in cash, cash equivalents and short-term investments Company …

United Fire Group, Inc. reports first quarter 2025 results

United Fire Group, Inc. reports first quarter 2025 results

First quarter net income of $0.67 per diluted share  and adjusted operating income of $0.70 per diluted share First quarter 2025 highlights compared to first quarter 2024, unless otherwise noted:(1) Net income increased 31% to $17.7 million. Net investment …

Power Smarter: leagend Battery Remote Monitoring Solution Revolutionizes Energy Management

Power Smarter: leagend Battery Remote Monitoring Solution Revolutionizes Energy Management

As industries increasingly rely on uninterrupted power for critical operations, leagend proudly introduces its Battery Remote Monitoring Solution. SHENZHEN, GUANGDONG, CHINA, May 6, 2025 /⁨EINPresswire.com⁩/ -- As industries increasingly rely on …

Acumen Pharmaceuticals to Report First Quarter 2025 Financial Results on May 13, 2025

Acumen Pharmaceuticals to Report First Quarter 2025 Financial Results on May 13, 2025

NEWTON, Mass., May 06, 2025 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) (“Acumen” or the “Company”), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta oligomers for the …

FLNC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Fluence Energy, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

FLNC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Fluence Energy, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

NEW YORK, May 06, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz …

UCTT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Ultra Clean Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

UCTT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Ultra Clean Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

NEW YORK, May 06, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz …

TMCI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Treace Medical Concepts, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

TMCI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Treace Medical Concepts, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

NEW YORK, May 06, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz …

TBBK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that The Bancorp, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

TBBK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that The Bancorp, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

NEW YORK, May 06, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz …

Cytokinetics Reports First Quarter 2025 Financial Results  and Provides Business Update

Cytokinetics Reports First Quarter 2025 Financial Results and Provides Business Update

PDUFA Date for Aficamten in Obstructive HCM Extended by FDA to December 26, 2025 Topline Results from MAPLE-HCM Expected in May Enrollment Completed in ACACIA-HCM; Topline Results Expected in 1H 2026 ~$1.1 Billion in Cash, Cash Equivalents and Investments …

Arcutis Announces First Quarter 2025 Financial Results and Provides Business Update

Arcutis Announces First Quarter 2025 Financial Results and Provides Business Update

Q1 2025 net product revenue for ZORYVE® (roflumilast) was $63.8 million, a 196% increase compared to Q1 of 2024, and a 2% decrease compared to Q4 of 2024, due to typical first-quarter deductible resets and insurance changes, and excluding the non-recurring …

Caribou Biosciences to Participate in the BofA Securities 2025 Health Care Conference

Caribou Biosciences to Participate in the BofA Securities 2025 Health Care Conference

BERKELEY, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced Rachel Haurwitz, PhD, Caribou’s president and chief executive officer, …

authID Announces Pricing of Approximately $2,100,000 Million Registered Direct Offering

authID Announces Pricing of Approximately $2,100,000 Million Registered Direct Offering

DENVER, May 06, 2025 (GLOBE NEWSWIRE) -- authID Inc. (NASDAQ: AUID) (“authID” or the “Company”), a leading provider of biometric identity verification and authentication solutions, today announced it has entered into a definitive agreement with investors …

First West combats hunger with $100,000 donation to Food Banks BC

First West combats hunger with $100,000 donation to Food Banks BC

LANGLEY, British Columbia, May 06, 2025 (GLOBE NEWSWIRE) -- First West Credit Union is proud to announce a donation of $100,000 to Food Banks BC, reinforcing its commitment to helping communities flourish and addressing food insecurity across British …

Draganfly to Host Shareholder Update Call on May 8, 2025

Draganfly to Host Shareholder Update Call on May 8, 2025

Saskatoon, SK, May 06, 2025 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8A) (“Draganfly” or the “Company”), an award-winning, industry-leading developer of drone solutions and systems, today announced that it will host a …

SOUND Behavioral Health Launches “Orange Door” Campaign for Mental Health Awareness Month

SOUND Behavioral Health Launches “Orange Door” Campaign for Mental Health Awareness Month

SEATTLE, May 06, 2025 (GLOBE NEWSWIRE) -- This May, in recognition of Mental Health Awareness Month, SOUND Behavioral Health is proud to launch the “Orange Door” campaign—a bold new initiative designed to raise awareness around the growing need for mental …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service